US 9693998
Compositions and methods of treating cardiac fibrosis with ifetroban
granted A61KA61K31/421A61K31/422
Quick answer
US patent 9693998 (Compositions and methods of treating cardiac fibrosis with ifetroban) held by Cumberland Pharmaceuticals Inc. expires Mon Jun 29 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Cumberland Pharmaceuticals Inc.
- Grant date
- Tue Jul 04 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 29 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/421, A61K31/422, A61K9/00, A61K9/0019